Market Quotes Powered By Forexpros, the Forex, Futures, and Stock Markets Portal.
Astepro approved in Europe
Tuesday, 20 March 2012
received registration approval in Europe via the decentralized
procedure. Astepro is a new nasal spray for the treatment of allergic
rhinitis. National registration processes, including price and
reimbursement, will now follow in each country. Launch is expected next
pleased to announce the approval of Astepro in Europe. The product has
been launched in the US with good success. With the addition of Dymista
(currently in registration phase) Meda will have an extraordinary
strong position in the allergy rhinitis area, both in the US and
Europe", said Anders Lönner, CEO of Meda AB.
What do you think about this
article or us? Please leave a comment. Thank you!